Diagnosis and treatment

FILE - In this April 9, 2020 file photo, a chemist displays hydroxychloroquine tablets in New Delhi, India. U.S. regulators are revoking emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19. The Food and Drug Administration said Monday, June 15 that the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. (AP Photo/Manish Swarup, File)
Associated Press
June 15, 2020 - 5:27 pm
WASHINGTON (AP) — U.S. regulators on Monday revoked emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 amid growing evidence they don’t work and could cause serious side effects. The Food and Drug Administration said the drugs hydroxychloroquine and...
Read More
President Donald Trump tells reporters that he is taking zinc and hydroxychloroquine during a meeting with restaurant industry executives about the coronavirus response, in the State Dining Room of the White House, Monday, May 18, 2020, in Washington. (AP Photo/Evan Vucci)
Associated Press
May 18, 2020 - 7:29 pm
WASHINGTON (AP) — President Donald Trump said Monday that he is taking a malaria drug to protect against the new coronavirus, despite warnings from his own government that it should only be administered for COVID-19 in a hospital or research setting due to potentially fatal side effects. Trump told...
Read More
Richard Bright, former director of the Biomedical Advanced Research and Development Authority, arrives for a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus outbreak, Thursday, May 14, 2020 on Capitol Hill in Washington. (Greg Nash/Pool via AP)
Associated Press
May 14, 2020 - 4:42 pm
WASHINGTON (AP) — Despite White House claims, the U.S. still lacks a comprehensive battle plan against the coronavirus in critical areas including masks, testing, treatments and vaccines, whistleblower Rick Bright warned Thursday in testimony before a House committee. “Our window of opportunity is...
Read More
FILE - In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)
Associated Press
May 01, 2020 - 6:08 pm
WASHINGTON (AP) — U.S. regulators on Friday allowed emergency use of the first drug that appears to help some COVID-19 patients recover faster, a milestone in the global search for effective therapies against the coronavirus. The Food and Drug Administration said in a statement that Gilead Science’...
Read More
FILE - This Monday, April 6, 2020, file photo shows an arrangement of Hydroxychloroquine pills in Las Vegas. At least 13 states have obtained a total of more than 10 million doses of malaria drugs to treat COVID-19 patients despite warnings from doctors that more tests are needed before the medications that President Trump once fiercely promoted should be used to help people with the coronavirus. (AP Photo/John Locher,File)
Associated Press
April 24, 2020 - 9:05 pm
SALT LAKE CITY (AP) — State and local governments across the United States have obtained about 30 million doses of a malaria drug touted by President Trump to treat patients with the coronavirus, despite warnings from doctors that more research is needed. At least 22 states and Washington, D.C.,...
Read More
Taiwan McCall, left, useless a nasal swab to test James Reese for COVID-19 in the Harlem section of New York, Monday, April 20, 2020. While many laboratories and companies are now offering tests, there are still only two main types available. The nasal swab test tells you if you have an active viral infection right now. A separate blood test tells you if you were previously exposed to the virus and fought off the infection. (AP Photo/Seth Wenig)
Associated Press
April 20, 2020 - 8:07 pm
WASHINGTON (AP) — Testing is critical to controlling the coronavirus and eventually easing restrictions that have halted daily life for most Americans. But there's been confusion about what kinds of tests are available and what they actually measure. There are still just two main types in the U.S...
Read More
President Donald Trump listens to a question from a reporter as he speaks about the coronavirus in the James Brady Press Briefing Room of the White House, Monday, April 6, 2020, in Washington. (AP Photo/Alex Brandon)
Associated Press
April 07, 2020 - 8:00 am
WASHINGTON (AP) — President Donald Trump and his administration are promoting an anti-malaria drug not officially approved for fighting the new coronavirus, even though scientists say more testing is needed before it’s proven safe and effective against COVID-19. Trump trade adviser Peter Navarro...
Read More
FILE - In this Saturday, March 28, 2020 handout photo provided by Number 10 Downing Street, Britain's Prime Minister Boris Johnson chairs the morning Covid-19 Meeting remotely after self isolating after testing positive for the coronavirus, at 10 Downing Street, London. British Prime Minister Boris Johnson has been admitted to a hospital with the coronavirus. Johnson’s office says he is being admitted for tests because he still has symptoms 10 days after testing positive for the virus. (Andrew Parsons/10 Downing Street via AP, File)
Associated Press
April 06, 2020 - 4:11 pm
LONDON (AP) — British Prime Minister Boris Johnson was moved to the intensive care unit of a London hospital after his coronavirus symptoms worsened Monday, just a day after he was admitted for what were said to be routine tests. Johnson was admitted to St. Thomas’ Hospital late Sunday, 10 days...
Read More
In this March 31, 2020 file photo pharmacist Amanda Frank reaches for a bottle of Hydroxychloroquine at the Medicine Shoppe in Wilkes-Barre, Pa. Some politicians and doctors are sparring over whether to use hydroxychloroquine against the new coronavirus, with many of scientists saying the evidence is too thin to recommend it now. (Mark Moran/The Citizens' Voice via AP, file)
Associated Press
April 06, 2020 - 1:55 pm
Some politicians and doctors are sparring over whether to use hydroxychloroquine against the new coronavirus, with many of scientists saying the evidence is too thin to recommend it now. HOW IS IT BEING USED? The drug can help tame an overactive immune system. It's been used since the 1940s to...
Read More
FILE - In this Monday, March 2, 2020 file photo, Gilead Sciences CEO Daniel O'Day speaks at a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House in Washington. Gilead, the pharmaceutical giant that makes remdesivir, a promising coronavirus drug, has registered it as a rare disease treatment with U.S. regulators on Monday, March 23, 2020, a status that can potentially be worth millions in tax breaks and competition-free sales. (AP Photo/Andrew Harnik)
Associated Press
March 24, 2020 - 9:11 pm
WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales. What that specialty status will actually mean for the...
Read More

Pages